Strengthening of Quality Assurance in HIV and Viral Hepatitis in Blood Banks

 

Recommendations

 

*     To Participants

 

*     The participants should develop standard operating procedures (SOP) for priority procedures, validate and use these in undertaking the procedure.

*     The participants should use internal quality control sera while screening for TTI.

 

*     To Member Countries

 

*     Member Countries should formulate a quality policy and implement it in all the blood banks.

*     The Blood Transfusion Services should screen the donated blood for HIV using one reliable screening kit as per WHO strategy. The management of donors whose blood is reactive should be undertaken only through a well defined national policy and with adequate infrastructure.

*     The procurement of the quality kits should be assured based upon the recommendations of a technical expert group. Bulk purchases make it economical and facilitate quality assurance by national authorities. Blood banks should preferably be supplied the same kit for long periods so that confidence in use of these kits is built up and data regarding their utility generated. Frequent replacement of makes and types of kits adversely influence the quality of screening.

*     Member Countries should strengthen infrastructure and skills to produce and distribute internal quality control sera.

*     Member Countries should impart training to their staff in BTS in quality aspects as a priority. WHO support may be sought in those areas where expertise and infrastructure are not available within the respective countries.

 

*     To WHO

 

*     WHO should support supply of internal quality control sera for HIV and hepatitis B and C to national laboratories/centres through regionally identified institutions for a period of two years.

*     Guidelines for the proper disposal of blood units that renders its disposal safe and environment-friendly should be developed.

*     Through a recognized centre in Region, WHO should assure continuous technical support to Member Countries in the quality of BTS.

*     WHO should develop a strategy for screening and testing of hepatitis B and hepatitis C in various settings and disseminate the same through national programme managers.

*     WHO should orient the national programme managers in proper use of WHO strategies for testing for HIV to bridge the existing gaps in use of these strategies.

 

 

 

||| | ||